Progress & Achievements » Licences
RAVIDASVIR
Patent Holder: Pharco Date: April 2017
In April 2017, the Medicines Patent Pool (MPP) and Pharco Pharmaceuticals signed a licence and technology agreement for ravidasvir, a direct-acting antiviral (DAA) with the potential of working across all six major hepatitis C genotypes.


Country List
Country List
Algeria, Azerbaijan, Belarus, Djibouti, Egypt, Ethiopia, Iran (Islamic Republic of), Iraq, Jordan, Kazakhstan, Lebanon, Libya, Morocco, Russian Federation, Syrian Arab Republic, Tunisia, Ukraine, State of Palestine, Yemen
Algeria, Azerbaijan, Belarus, Djibouti, Egypt, Ethiopia, Iran (Islamic Republic of), Iraq, Jordan, Kazakhstan, Lebanon, Libya, Morocco, Russian Federation, Syrian Arab Republic, Tunisia, Ukraine, State of Palestine, Yemen